It has been observed that repeated doses of DCA resulted in loss of GSTZ1-1 protein and activity, probably due to post-translationally modifications of the enzyme 85
"A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies"
after all, a person can be hypersensitive to anything, even things that occur naturally in the body
According to a recent report by Morgan Stanley, the global market for obesity drugs is expected to increase 15-fold by 2030, driven by their expanding use beyond weight loss to address various obesity-related conditions
Use an alcohol wipe to sterilize the top of each vial
Front Pharmacol 14(September):123 Kreymann B, Ghatei MA, Williams G, Bloom SR (1987) Glucagon-like peptide-1 736: a physiological incretin in man